HMS Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,700
Closed -$651K 84
2019
Q4
$651K Hold
2,700
0.27% 89
2019
Q3
$522K Buy
2,700
+400
+17% +$76.8K 0.19% 131
2019
Q2
$424K Sell
2,300
-600
-21% -$107K 0.18% 120
2019
Q1
$551K Buy
2,900
+600
+26% +$115K 0.23% 112
2018
Q4
$448K Buy
+2,300
New +$449K 0.23% 112

Other funds holding AMGN

HMS Capital Management's AMGN Position: Q1 2022 in Review

HMS Capital Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 1,716 shares — an estimated $386K sold.

HMS Capital Management first reported a position in AMGN in Q4 2018 and held it in 13 quarters. The position peaked at $1.2M in Q4 2019. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • HMS Capital Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • HMS Capital Management sold 1,716 Amgen shares in Q1 2022, an estimated $386K.
  • HMS Capital Management first reported a position in Amgen in Q4 2018 and held it in 13 quarters.
  • HMS Capital Management's Amgen position peaked at $1.2M in Q4 2019.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on HMS Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.